- Generic name
- Sacubitril + Valsartan
- Strength
- 97 mg + 103 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
Sacuva 200 Tablet
About Sacuva 200 97 mg + 103 mg Tablet
The tablet Sacuva 200 contains Sacubitril + Valsartan and is made by The ACME Laboratories Ltd. Sacuva 200 is used in adults with chronic heart failure and reduced ejection fraction to lower the risk of cardiovascular death and hospitalisation for heart failure.
There are 25 brands of Sacubitril + Valsartan listed in Bangladesh. The lowest listed price is Arnis 24 mg+26 mg Tablet at ৳ 35.00 per unit.
What is Sacuva 200 97 mg + 103 mg Tablet?
Sacuva 200 is a tablet from The ACME Laboratories Ltd., with the generic name Sacubitril + Valsartan. It belongs to a group of medicines that act on the heart and blood vessels to help manage heart failure. It works by increasing certain natural peptides and blocking a substance that raises blood pressure. The dose and course are decided by the doctor.
Uses of Sacuva 200
Sacuva 200 is used in adults with chronic heart failure and reduced ejection fraction to lower the risk of cardiovascular death and hospitalisation for heart failure. It is also used for symptomatic heart failure with left ventricular systolic dysfunction in children aged one year and older. Ask your doctor whether it is right for your condition.
How to use Sacuva 200
If a dose is missed, ask the doctor or pharmacist what to do. Sacuva 200 is taken by mouth. Swallow the tablet with water. The doctor decides the starting dose, any later change in dose, and how long you take it. Do not stop or change the dose on your own, even if you feel better, because heart failure treatment works over time.
Side effects of Sacuva 200
Your doctor may check your blood pressure, kidney function and potassium while you take this medicine. Your doctor may need to adjust your treatment. Your doctor may monitor your kidney function and potassium levels during treatment. Tell your doctor straight away if you have trouble breathing, swelling, or feel very dizzy or faint. Tell your doctor if you notice swelling, dizziness, or feel unwell.
Safety and precautions
Elderly patients can take it without dose adjustment. Sacuva 200 is not safe during pregnancy because it can harm the unborn baby. It may lower blood pressure; the doctor will monitor kidney function and potassium. Ask your doctor before use if you have kidney or liver problems or take other medicines.
Frequently asked questions
Why is Sacuva 200 prescribed?
Sacuva 200 is used in adults with chronic heart failure and reduced ejection fraction to lower the risk of cardiovascular death and hospitalisation for heart failure. It is also used for symptomatic heart failure with left ventricular systolic dysfunction in children aged one year and older.
How should I take Sacuva 200?
If a dose is missed, ask the doctor or pharmacist what to do. Sacuva 200 is taken by mouth.
What should I watch for while using Sacuva 200?
Your doctor may check your blood pressure, kidney function and potassium while you take this medicine. Your doctor may need to adjust your treatment.
Can I use Sacuva 200 in pregnancy or while breastfeeding?
Elderly patients can take it without dose adjustment. Sacuva 200 is not safe during pregnancy because it can harm the unborn baby.
Indications
- To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class ll-IV) and reduced ejection fraction.
- For the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. ... Read more
- To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class ll-IV) and reduced ejection fraction.
- For the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older.
- This is usually administered in conjunction with other heart failure therapies, in place of an angiotensin-converting enzyme inhibitor (ACEi) or other ARB.
Pharmacology
Dosage & Administration
Reduce the starting dose to 24/26 mg twice daily for:
- Patients not currently taking an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) or previously taking a low dose of these agents.
- Patients with severe renal impairment.
- Patients with moderate hepatic impairment.
Recommended Dose Titration-
Pediatric Patients Less than 40 kg:
- Starting: 1.6 mg/kg
- Second: 2.3 mg/kg
- Final: 3.1 mg/kg
- Starting: 24/26 mg
- Second: 49/51 mg
- Final: 49/51 mg
- Starting: 49/51 mg
- Second: 72/78 mg
- Final: 97/103 mg
Interaction
Potassium-sparing Diuretics: Serum potassium level may be increased.
NSAIDs: Risk of renal impairment may be increased.
Lithium: Increased risk of lithium toxicity.
Contraindications
- In patients with hypersensitivity to any component
- In patients with a history of angioedema related to previous ACE inhibitor or ARB therapy
- With concomitant use of ACE inhibitors. Do not administer within 36 hours of switching from or to an ACE inhibitor
- With concomitant use of aliskiren in patients with diabetes
Side Effects
Pregnancy & Lactation
Geriatric Use: No relevant pharmacokinetic differences have been observed in elderly (>65 years) or very elderly (>75 years) patients compared to the overall population.
Hepatic Impairment: No dose adjustment is required when administering this tablet to patients with mild hepatic impairment (Child-Pugh A classification). This tablet is not recommended in patients with severe hepatic impairment, as no studies have been conducted in these patients.
Renal Impairment: No dose adjustment is required in patients with mild (eGFR 60 to 90 ml/min/1.73 m2) to moderate (eGFR 30 to 60 ml/min/1.73 m2) renal impairment. The recommended starting dose in patients with severe renal impairment (eGFR <30 ml/min/1.73 m2) is 24/26 mg twice daily.
Precautions & Warnings
This tablet lowers blood pressure and may cause symptomatic hypotension. Closely monitor serum creatinine, and down-titrate or interrupt this tablet in patients who develop a clinically significant decrease in renal function. In patients with renal artery stenosis, monitor renal function.
Monitor serum potassium periodically and treat appropriately, especially in patients with risk factors for hyperkalemia such as severe renal impairment, diabetes, hypoaldosteronism, or a high potassium diet. Dosage reduction or interruption of this tablet may be required.
Overdose Effects
Storage Conditions
Alternative brands of Sacubitril + Valsartan
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.